World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
115
Citations
72810
World Ranking
4437
National Ranking
2419

Richard C. Becker publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Richard C. Becker sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 826 publications — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Richard C. Becker D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Richard C. Becker sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 115 D-Index — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Richard C. Becker is affiliated with the University of Cincinnati in the United States. Their primary research fields are Medicine, with a particular focus on Cardiology and Cardiovascular Medicine.

Their work spans several main topics related to cardiac health, including:

  • Atrial Fibrillation Management and Outcomes
  • Cardiac Valve Diseases and Treatments
  • Cardiac Arrhythmias and Treatments

Among recent publications, a notable paper is "Rationale and design of PROACT Xa: A randomized, multicenter, open-label, clinical trial to evaluate the efficacy and safety of apixaban versus warfarin in patients with a mechanical On-X Aortic Heart Valve," published in 2020 in the American Heart Journal.

Frequent co-authors collaborating with Becker include:

  • Oliver K. Jawitz
  • Tracy Y. Wang
  • Renato D. Lópes
  • Alma Chavez
  • Brittanny Boyer

Their contributions have appeared primarily in the American Heart Journal, reflecting their engagement with cardiovascular research communities and clinical study publications.

Best Publications

  • Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

    Manesh R. Patel;Kenneth W. Mahaffey;Jyotsna Garg;Guohua Pan

  • Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

    Lars Wallentin;Richard C. Becker;Andrzej Budaj;Christopher P. Cannon

  • Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine Diphosphate

    Laurent Bonello;Udaya S. Tantry;Rossella Marcucci;Ruediger Blindt

  • Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis

    S. G. Chu;R. C. Becker;P. B. Berger;D. L. Bhatt

  • Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation

    Abstr Act;James D. Douketis;Alex C. Spyropoulos;Scott Kaatz

  • The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

    James D. Douketis;Peter B. Berger;Andrew S. Dunn;Amir K. Jaffer

  • Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial.

    James J Ferguson;Robert M Califf;Elliott M Antman;Marc Cohen

  • Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

    Iacopo Olivotto;Artur Oreziak;Roberto Barriales-Villa;Theodore P. Abraham

  • Consensus and Update on the Definition of On-Treatment Platelet Reactivity to Adenosine Diphosphate Associated With Ischemia and Bleeding

    Udaya S. Tantry;Laurent Bonello;Daniel Aradi;Matthew J. Price

  • Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study

    Christopher P Cannon;Robert A Harrington;Stefan James;Diego Ardissino

  • Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment

    Keith A. A. Fox;Jonathan P. Piccini;Daniel Wojdyla;Richard C. Becker

  • Platelet Inhibition with Cangrelor in Patients Undergoing PCI

    Robert A. Harrington;Gregg W. Stone;Steven McNulty;Harvey D. White

  • Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial

    Lars Wallentin;Stefan James;Robert F Storey;Martin Armstrong

  • COVID-19 update: Covid-19-associated coagulopathy.

    Richard C. Becker

  • Platelet functions beyond hemostasis

    S. S. Smyth;R. P. Mcever;A. S. Weyrich;C. N. Morrell

  • Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease

    Mark I Furman;Stephen E Benoit;Marc R Barnard;C.Robert Valeri

  • Response to Letter Regarding Article, “Renal Dysfunction as a Predictor of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial Fibrillation: Validation of the R2CHADS2 Index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study Cohorts”

    Jonathan P. Piccini;Susanna R. Stevens;YuChiao Chang;Daniel E. Singer

  • Sex differences in mortality following acute coronary syndromes.

    Jeffrey S. Berger;Laine Elliott;Dianne Gallup;Matthew Roe

  • Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial.

    Investigators;John H Alexander;Richard C Becker

  • Seasonal distribution of acute myocardial infarction in the second National Registry of Myocardial Infarction.

    Frederick A. Spencer;Robert J. Goldberg;Richard C. Becker;Joel M. Gore

Frequent Co-Authors

Kenneth W. Mahaffey
Kenneth W. Mahaffey Stanford University
Manesh R. Patel
Manesh R. Patel Duke University
Keith A.A. Fox
Keith A.A. Fox University of Edinburgh
Stefan James
Stefan James Uppsala University
Daniel E. Singer
Daniel E. Singer Harvard University
Robert F. Storey
Robert F. Storey University of Sheffield
Lars Wallentin
Lars Wallentin Uppsala University
Graeme J. Hankey
Graeme J. Hankey University of Western Australia
Jonathan P. Piccini
Jonathan P. Piccini Duke University
Jonathan L. Halperin
Jonathan L. Halperin Icahn School of Medicine at Mount Sinai

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in medicine goes beyond traditional medical school. Today, many students are exploring alternative healthcare pathways that offer flexibility, affordability, and quicker entry into the workforce. If you're interested in medical support roles, check out the best online medical billing and coding schools to gain skills essential for managing health records, insurance, and billing processes.

For those aiming to start their nursing careers quickly, some schools offer an lpn program no entrance exam required. This makes it easier to begin training as a licensed practical nurse without lengthy or complicated admissions tests.

Interested in leadership or administrative roles within healthcare? Earning a healthcare administration degree online accredited can prepare you for positions in hospital management, department operations, or policy making.

Finally, registered nurses seeking advanced clinical qualifications can explore asn to fnp bridge programs. These accelerated pathways help nurses move quickly from associate degrees to becoming Family Nurse Practitioners, expanding their career and earning potential.

Best Scientists Citing Richard C. Becker

Trending Scientists

Recently Published Articles